| Phase | Proposed Timeline |
| Workgroup Phase | January - March 2013 (Completed) |
| Implementation Phase with PQA | February - July 2013 (Completed) |
| Enrollment and Implementation | July - September 2013 (Completed) |
| Phase I Launch | October 2013 (Completed) |
| Bi-Annual Evaluation | April - May Annually (Ongoing) |
| Phase II Preparation (Changes in Measurements and Threshold) | March 2014 |
| Phase II Launch (Changes in Measurements and Threshold) | October 2015 (Completed) |
| Phase III (Outcome-based MTM Program) | Tentative Launch Date - January 2016 |
**All schedules are subject to change
P4P Threshold Measures (NEW 2015-2016)
| For IEHP P4P Program Report Card Use | |||||||
| Measures | 1st Target | BonusTarget | 1 Star | 2 Star | 3 Star | 4 Star | 5 Star |
| Proportion of Day Covered - Diabetes | 80.40% | 88.20% | <76.4% | 76.4 - 80.3% | 80.4-84.3% | 84.4-88.2% | ≥88.3% |
| Proportion of Day Covered - HTN | 80.30% | 86% | <76.3% | 76.3 - 80.2% | 80.3-83.2% | 83.3-85.9% | ≥86% |
Proportion of Day Covered - Statins
|
78.30%
| 84.90% |
<74.3%
| 74.3 - 78.2% | 78.3 - 81.2% | 81.3 - 84.9% | ≥85% |
Statin Use in Persons with Diabetes
|
60.70%
| 69% |
<56.7%
| 56.7 - 60.6% | 60.7 - 64.6% | 64.7 - 69% | ≥69.1% |
Asthma - Absence of Controller Therapy
|
58.30%
| 40% |
>62.3
| 58.4 - 62.3% | 49.4 - 58.3% | 40.1-49.3% | ≤40% |
| Asthma - Suboptimal Control |
17.70%
|
10.50%
|
>20.7%
|
17.8 - 20.7%
|
14.8 - 17.7%
|
10.6 - 14.7%
|
≤10.5%
|
Use of High-Risk Medications in the Elderly
|
11.50%
| 5.30% |
>13.6
| 11.6 - 13.6% | 7.6 - 11.5% | 5.2 - 7.5% | ≤5.1% |
Generic Dispensing Rate (GDR)
|
83%
| 85% |
78-78.9%
| 80 - 82.9% | 83 - 83.9% | 84-84.9% | ≥85% |
0 التعليقات:
إرسال تعليق